the aid library

A Global Perspective on Pyrazinamide Resistance: Systematic Review and Meta- Analysis

M. G. Whitfield, H. M. Soeters, R. M. Warren, et al. PLOS One; I. Mokrousov, (St. Petersburg Pasteur Institute) (2015) CC

PLOS ONE | DOI:10.1371/journal.pone.0133869 July 28, 2015, p.1-16

Tuberculosis and HIV Co-Infection

A. Pawlowski, M. Jansson, M. Sköld, et al. PLOS Phatogens (2012) CC

PLoS Pathogens | www.plospathogens.org 1 February 2012 | Volume 8 | Issue 2 | e100246

Recent Advances in the Management Strategies for Buruli Ulcers

Popa G.; Muntean Al., Popa M. (2023) CC

Buruli ulcer (BU) is a bacterial skin infection that is caused by Mycobacterium ulcerans and mainly affects people who reside in the rural areas of Africa and in suburban and beach resort communities in Australia.

Developing the Resilience Framework for Nursing and Healthcare

Morse, J.M.; et al. (2021) CC

Global Qualitative Nursing Research March 31, 2021 Research Article Find in PubMed https://doi.org/10.1177/23333936211005475

The Impact of Tuberculosis among Immigrants: Epidemiology and Strategies of Control in High-Income Countries—Current Data and Literature Review

C. Contini, M. Maritari, M. die Nuzzo, et al. INTECH (2017) CC

World's largest Science, Technology & Medicine Open Access book publisher Chapter 7 from the book People's Movements in the 21st Century - Risks, Challenges and Benefits

Green spaces and mortality: a systematic review and meta-analysis of cohort studies

Rojas-Rueda, D.; M.J. Nieuwenhuijsen, M. Gascon; et al. (2019) CC

Lancet Planet Health 2019; 3: 469–77

Ten Years of Traditional Contraceptive Method Use in the Philippines: Continuity and Change

M. Paz N. Marquez; M.M.M. Kabamalan and E.P. Laguna USAID (2017) C1

Demographic Health Survey Working Paper 2017 No. 130

Tuberculosis control in prisons: current situation and research gaps

M. Dara, C. D. Acosta, M. V. S. Vinklers Melchers, et al. International Journal of Infectious Diseases (2015) C2

International Journal of Infectious Diseases 32 (2015) 111–117

Government policy interventions to reduce human antimicrobial use: A systematic review and evidence map

Van Katwyk, S. R.; Grimshaw, J. M.; et al (2019) C2

BACKGROUND: Growing political attention to antimicrobial resistance (AMR) offers a rare opportunity for achieving meaningful action. Many governments have developed national AMR action plans, but most have not yet implemented policy interventions to reduce antimicrobial overuse. A systematic evidenc ... e map can support governments in making evidence-informed decisions about implementing programs to reduce AMR, by identifying, describing, and assessing the full range of evaluated government policy options to reduce antimicrobial use in humans. METHODS AND FINDINGS: Seven databases were searched from inception to January 28, 2019, (MEDLINE, CINAHL, EMBASE, PAIS Index, Cochrane Central Register of Controlled Trials, Web of Science, and PubMed). We identified studies that (1) clearly described a government policy intervention aimed at reducing human antimicrobial use, and (2) applied a quantitative design to measure the impact. We found 69 unique evaluations of government policy interventions carried out across 4 of the 6 WHO regions. These evaluations included randomized controlled trials (n = 4), non-randomized controlled trials (n = 3), controlled before-and-after designs (n = 7), interrupted time series designs (n = 25), uncontrolled before-and-after designs (n = 18), descriptive designs (n = 10), and cohort designs (n = 2). From these we identified 17 unique policy options for governments to reduce the human use of antimicrobials. Many studies evaluated public awareness campaigns (n = 17) and antimicrobial guidelines (n = 13); however, others offered different policy options such as professional regulation, restricted reimbursement, pay for performance, and prescription requirements. Identifying these policies can inform the development of future policies and evaluations in different contexts and health systems. Limitations of our study include the possible omission of unpublished initiatives, and that policies not evaluated with respect to antimicrobial use have not been captured in this review. CONCLUSIONS: To our knowledge this is the first study to provide policy makers with synthesized evidence on specific government policy interventions addressing AMR. In the future, governments should ensure that AMR policy interventions are evaluated using rigorous study designs and that study results are published. more

Air pollution exposure—the (in)visible risk factor for respiratory diseases

Bălă, G.P.; Râjnoveanu, R.M.; Tudorache, E. et al. Environmental Science and Pollution Research (2021) CC

There is increasing interest in understanding the role of air pollution as one of the greatest threats to human health worldwide. Nine of 10 individuals breathe air with polluted compounds that have a great impact on lung tissue. The nature of the relationship is complex, and new or updated data are ... more

The role of soil in defining planetary boundaries and the safe operating space for humanity

Kopittke, P.M.; et al. (2021) CC

Environment International Volume 146, January 2021, 106245. We use soils to provide 98.8% of our food, but we must ensure that the pressure we place on soils to provide this food in the short-term does not inadvertently push the Earth into a less hospitable state in the long-term. Using the planeta ... more

A conceptual framework for the environmental surveillance of antibiotics and antibiotic resistance

Patricia M.C. Huijbers, Carl-Fredrik Flach, D.G. Joakim Larsson Centre for Antibiotic Resistance Research (CARe), University of Gothenburg (2019) C2

The systematic surveillance of antibiotic use and antibiotic re-sistance prevalence in humans and animals is imperative for managingbacterial infectious disease (JPIAMR, 2019;WHO, 2015). Many low-income countries currently face substantial challenges in building national surveillance systems due to ... more

Cardiovascular Diseases in Sub-Saharan Africa Compared to High-Income Countries: An Epidemiological Perspective

Yuyun, M.F.; Sliwa, K.; Kengne, A.P. et al. Global Heart (2020) CC

Non-communicable diseases (NCDs) are the second common cause of death in sub-Saharan Africa (SSA) accounting for about 35% of all deaths, after a composite of communicable, maternal, neonatal, and nutritional diseases. Despite prior perception of low NCDs mortality rates, current evidence suggests t ... more

Assessing Health Vulnerabilities and Adaptation to Climate Change

Berry, P.; P. M. Enright, J. Shumake-Guillemot et al. (2018) CC

Int. J. Environ. Res. Public Health 2018, 15(12), 2626; https://doi.org/10.3390/ijerph15122626 Climate change is increasing risks to human health and to the health systems that seek to protect the safety and well-being of populations. Health authorities require information about current associatio ... more

Mетодические рекомендации - Oсобенности клинических проявлений и лечения заболевания, вызванного новой коронавирусной инфекцией (Covid-19) у детей Версия 2 (03.07.2020)
recommended

Александрович Ю.С., Алексеева Е.И., Бакрадзе М.Д., et al. Министерство здравоохранения Российской Федерации (2020) C2

Oсобенности клинических проявлений и лечения заболевания, вызванного новой коронавирусной инфекцией (Covid-19) у детей (clinical guidelines pediatrics)